Investors in It

Open CNP is the corporate venture program of CNP Assurances. Launched in 2016, Open CNP is the corporate venture capital fund of CNP Assurances. We invest through our €100m fund in Seed to Series B opportunities. Supporting innovative European startups that are building the future of finance, insurance, health and B2B services.

Banca Sella offers is a wide range of financial and banking products to meet its customers’ needs, mixing the benefits of specialization with tailor-made solutions. Gruppo Banca Sella's network can count on 300 branches and its companies operate all over Italy, also having subsidiaries in India and Romania. Banca Sella participates in the information campaign to safely use digital channels and tools promoted by CERTFin, together with Banca d'Italia, Abi, Ivass and other credit institutions.

BOLD (Business Opportunities for L'Oréal Development) is a venture fund of L'Oréal. BOLD is the strategic venture capital fund of L'Oréal. We invest in brands, technology, and biotech & green science that are redefining the frontier of beauty. We partner with the next generation of beauty innovators and disruptors to create the beauty that moves the world.

Corporate capital investment fund that propels seed stage startups to the next level to transform agri-food systems.ResiliAnce is the corporate capital investment fund that accelerates the digital, economic, and sustainable transformation of global agro industrial systems.

Due to the challenges of increasingly scarce resources, we must speed up the development and implementation of radically new solutions. Our innovation ecosystem calls on a worldwide network of centers of excellence in collaboration with the world’s leading research centers. We also work with a generation of pioneering start-ups.

Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals. Our primary focus is to identify and invest in emerging companies in the digital health space, globally, that could enhance Hikma’s value proposition, reputation and market intelligence. We will also consider investments in other healthcare related areas of current or future strategic interest to Hikma, including drug delivery technologies that have the potential to enhance Hikma's value chain and pipeline.

Launched as Bonnier Growth Media in 2013, Bonnier Ventures is the venture arm of media group Bonnier. As a financially driven corporate venture investor, they make minority investments in fast growing digital technology companies across multiple growth stages. Bonnier Capital is the investment division of the Bonnier Group, a Swedish based family owned group within media, publishing and real estate. The Bonnier Group has partnered with entrepreneurs for almost 200 years to enable innovation and the fostering of ideas and new businesses.

Abundant energy, automated. We’re building Energy Artificial General Intelligence (Energy AGI) to automatically and autonomously supply the world with low-carbon energy at stable prices. Virtus is on a mission to facilitate the Energy Transition, focusing on renewable and low-carbon energy. Our activities concentrate on physical energy, related supply chain flows and infrastructure.

A subsidiary of Swiss health insurance Helsana, our goal is to improve efficiency and the provision of care in the Swiss healthcare system. Helsana Health Invest invests in start-ups dedicated to health. It’s our way of contributing to a higher quality of healthcare and increasing efficiency in the healthcare system. Helsana: Switzerland's top health insurer offering comprehensive health and accident insurance services to individuals and companies, with over 1.9 million policyholders and a strong focus on prevention and occupational health management.

Henkel Ventures is Henkel’s corporate venture capital engagement, combining all venture activities across the company’s three business units (Adhesive Technologies, Beauty Care and Laundry & Home Care). Henkel Ventures actively evaluates and manages equity investments and joint development projects with start-up companies to explore new technologies, applications and business models in areas of strategic interest for Henkel. Leading with our innovations, brands and technologies. We are: Pioneers at heart for the good of generations.

Evonik Venture Capital is the corporate venture arm of Evonik Industries AG, one of the providers of specialty chemicals. Evonik Venture Capital invests in young companies with innovative technology and high growth potential with solutions to problems within the areas of focus of resource efficiency, specialty additives, health & care, nutrition. Leading in specialty chemicals and beyond to make the world a better place. We are an international group with a workforce of over 32,000 people spread across more than one hundred locations.

MKB Fintechlab is a Budapest-based startup accelerator backed by MKB Bank. Our 12-week acceleration program is focused on bringing fintech startups to the next level and bringing them commercial partnerships with MKB Bank. Besides workshops, mentoring, workspace and tons of door openings, the accelerator provides a sandbox which is an API platform for startups to access MKB Bank’s development and testing environment.